Clinical Trial Update: Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression [Phase 1]

View source ↗

Summary

A Phase 1 study is evaluating the neurobiological effects of psilocybin in treatment-resistant bipolar depression and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Bipolar Depression | Phase 1 | Status: RECRUITING